Skip to content
Billionaire Profile
Friederike Braun-Luedicke
Global Rank
#2024

Friederike Braun-Luedicke

CEO, Medical technology
Melsungen, Germany
Real-Time Net Worth
$2.05B
Estimated based on Medical technology stock value as of September 10, 2026
0% (24h)
Age
42
Source
Medical technology
Industry
Healthcare
Citizenship
Germany

Biography

Friederike Braun-Luedicke is a German billionaire and a sixth-generation member of the Braun family, whose wealth stems from B. Braun Melsungen, a global medical and pharmaceutical device company. Her estimated net worth is $2.1 billion. She works as a Manager in Personnel and Organizational Development at B. Braun. Her career involves the operational side of the family business, reflecting her deep commitment to the company's long-term legacy and organizational efficiency.

AI-Assisted Draft
Not yet reviewed by an editor — how we work
Data Updated
Sep 10, 2026
Report a Correction

Wealth Over Time

Net Worth History

YearNet Worth
2026$2.05B
2025$2.10B
2024$2.10B

Portfolio Holdings

B. Braun Melsungen

B. Braun Melsungen

healthcare
$1.81B
Holdings Value
Ownership
12%
Revenue
$9.10B
Melsungen, Germany
60,000 employees
Founded 1839

In-Depth Profile

Friederike Braun-Luedicke's wealth originates from her ownership stake in B. Braun Melsungen, a significant global player in the medical technology industry. As a sixth-generation member of the Braun family, her connection to the company is deeply rooted in its history, tracing back to its founding as a pharmacy in Melsungen, Germany. Over the centuries, B. Braun Melsungen has evolved from a local establishment into a leading international provider of healthcare solutions. The company's core activities revolve around the manufacturing and supply of a diverse range of medical and pharmaceutical devices. This extensive product portfolio includes essential items such as infusion and injection solutions, crucial for patient care in hospitals and clinics worldwide, as well as sophisticated surgical instruments used in various medical procedures. The breadth of its offerings underscores its integral role in global public health, providing critical supplies that support medical professionals and patient well-being across numerous countries.

The foundation of Friederike Braun-Luedicke's financial standing is directly linked to her inheritance and ongoing ownership within B. Braun Melsungen, which remains a privately held, family-owned enterprise. The company's ownership structure involves multiple members of the Braun family, with Friederike being one of the key stakeholders. This familial ownership model has allowed the company to maintain its long-term strategic vision and independence, distinguishing it from publicly traded corporations. The substantial value of B. Braun Melsungen, driven by its expansive global operations, continuous innovation in medical technology, and consistent demand for its essential products, translates directly into the significant net worth of its owners, including Friederike Braun-Luedicke. Her share in this flourishing enterprise forms the basis of her considerable wealth.

Friederike Braun-Luedicke's career within B. Braun Melsungen demonstrates her active involvement in the operational aspects of the family business. She currently serves as a Manager in Personnel and Organizational Development, a role that places her at the heart of the company's human resources and structural efficiency. This position highlights her commitment to the internal workings and long-term sustainability of the organization. Her work in personnel and organizational development is critical for fostering a skilled workforce, ensuring effective management structures, and promoting a corporate culture that supports the company's goals and values. This operational focus reflects a direct engagement with the business rather than a passive ownership role, showing her dedication to contributing to its ongoing success and legacy.

Further underscoring her commitment to the governance and strategic direction of B. Braun Melsungen, Friederike Braun-Luedicke became a Member of the Supervisory Board of B. Braun SE in a recent year. This appointment to the supervisory board is a significant career milestone, elevating her role beyond day-to-day management to one of oversight and strategic guidance for the entire organization. As a member of the supervisory board, she participates in critical decisions regarding the company's overall direction, financial performance, and adherence to corporate governance standards. This position not only signifies her influence within the company but also her active participation in shaping its future trajectory, ensuring that B. Braun Melsungen continues to thrive as a global leader in the medical technology industry while upholding its family-owned principles and deep commitment to healthcare provision.

Career Milestones

2021

Member of the Supervisory Board

Member of the Supervisory Board of B. Braun SE

Manager in Personnel and Organizational Development

Works for B. Braun as a Manager in Personnel and Organizational Development

Philanthropy & Social Impact

Health

Community and Health Initiatives

Supports various community and health initiatives

Billionaires Connected to Friederike Braun-Luedicke

Peers in Healthcare

All Healthcare billionaires

Adjacent Global Ranks

Full global ranking

Frequently Asked Questions

What is Friederike Braun-Luedicke's net worth in 2026?
As of 2026, Friederike Braun-Luedicke's estimated net worth is $2.054 billion, ranking #2024 among the world's billionaires. The estimate is based on publicly available shareholding data and market prices, updated daily.
How did Friederike Braun-Luedicke make their money?
Friederike Braun-Luedicke's wealth primarily comes from Medical technology, most notably through Medical technology.
Where is Friederike Braun-Luedicke from?
Friederike Braun-Luedicke is from Germany.
How old is Friederike Braun-Luedicke?
Friederike Braun-Luedicke is 42 years old.

Sources & References

Citations for this profile have not been published yet. Net worth figures here are estimates and should not be treated as verified. See our methodology for how these estimates are produced, or report a correction.